Pillstats
Rx only · Tablet, Extended Release · Oral

Pentoxifylline

Pentoxifylline

6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US7 NDCs
6 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)8013
US makers6 labelers
Packages17
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 7 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.070$0.141$0.211$0.281Dec 2025Apr 2026Jul 2026
$0.233
Latest avg · Jul 22, 2026
+4%
Since Dec 17, 2025
6
Active US suppliers
65%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

11K22K33K43K2025 Q12025 Q22025 Q32025 Q42026 Q1
34K
Rx · 2026 Q1
2.2M
Units dispensed
-9%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it6 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bryant Ranch Prepackrepackager6SUPPLYING
Rising Pharma Holdings, Inc.unknown5SUPPLYING
ANI Pharmaceuticals, Inc.unknown2SUPPLYING
Apotex Corp.unknown2SUPPLYING
NCS HealthCare of KY, LLC dba Vangard Labsunknown1SUPPLYING
Major Pharmaceuticalsunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.